MedTrace Logo

Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients

NCT04394585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-04-13

No results posted yet for this study

Summary

This study is a single center, prospective, randomized controlled study. The aim of this study is to evaluate the effect of smart phone app-based human coaching program on QOL in patients who underwent gastrectomy for stage I gastric cancer. The hypothesis of this study is the patients who used smart phone app-based human coaching program for three months after surgery will have better QOL than patients who did not use it. The QOL will be assessed using EORTC QLQ C30 and STO22 at 3 months postoperatively. The secondary endpoints are QOL at 6 months postoperatively, 12 months postoperative, food intake, body composition, and nutritional indicators from blood test.

Conditions

  • Stage I Gastric Cancer

Interventions

BEHAVIORAL

smart phone app based human coaching program

1. experimental arm * 1:1 coaching using smart phone app * Patients are provided several articles about postoperative care (symptom management, diet, and exercise) in the app. * Patients are encouraged to report their diet diaries and exercise everyday by the coach. * Patients can ask to the coach using the app and the coach answer when they check them. 2. Comparator arm - Patient have consulting with clinical nutritionist at 1 month and 3 months postoperatively.

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2022-11-02
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394585 on ClinicalTrials.gov